Addex TherapeuticsADXN
13F holders, Q1 2025 (March 31)5holders
0new positions
0sold out
1famous investor
$7.34avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Addex Therapeutics Ltd. (ADXN) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($86K), GAMMA Investing LLC ($9K) and Morgan Stanley ($734). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Addex Therapeutics Ltd.
- CUSIP
- 00654J206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 182 shares bought and 2,173 shares sold, net −1,991 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Citadel Advisors | 0.00% | Reduce -2.8% | 11,741 | $86K |
| GAMMA Investing LLC | 0.00% | Add +18.0% | 1,193 | $9K |
| Morgan Stanley | 0.00% | Reduce -94.7% | 100 | $734 |
| Rhumbline Advisers | 0.00% | Reduce -32.7% | 72 | $528 |
| SBI Securities Co., Ltd. | 0.00% | No change | 5 | $37 |
"% of holder's portfolio" is ADXN's weight in each manager's 13F, not the share of Addex Therapeutics Ltd. the manager owns.